Basic Attention Token vs Enzyme — how do they compare? Basic Attention Token trades at Rp1,030 (market cap Rp1,54T, Rp116,59M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Basic Attention Token is far larger — about 11481.4× Enzyme's market cap, and Basic Attention Token's supply is capped (1,5B / 1,5B BAT (100%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Basic Attention Token for 91 Days and Enzyme for 29 Days on average.
| BAT | MLN | |
|---|---|---|
Market Cap | Rp1,54T | Rp134,13M |
Volume (24h) | Rp116,59M | Rp104,56M |
Circulating Supply | 1,5B / 1,5B BAT (100%) | 3,3M MLN |
Typical Hold Time | 91 Days | 29 Days |
Signals from Pluang's Aura AI — not financial advice
Basic Attention Token (BAT) is currently trading at Rp1,039 with a market cap of Rp1.55 trillion, showing a fully diluted supply. Technical indicators present a mixed signal: moving averages are bearish, but oscillators are bullish, with RSI levels suggesting potential oversold conditions. The current price is near support level S3 at Rp1,032. No major protocol updates or ecosystem news are reported recently.
Overall outlook is cautious due to conflicting technical signals and lack of fundamental catalysts. Key opportunities include potential rebounds from oversold RSI levels, while major risks involve high volatility, bearish trend pressure, and limited recent network developments. Investors should monitor support breaks and trading volume changes closely.
Enzyme (MLN) shows limited market activity with a market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates a relatively short hold time of 29 days, suggesting active trading patterns. Current technical positioning requires updated price data for comprehensive analysis. Recent ecosystem developments appear limited based on available information.
Overall outlook remains cautious due to limited market data and ecosystem activity. Key opportunities include potential protocol upgrades and increased adoption, while major risks involve low liquidity and market volatility. Investors should monitor on-chain metrics and exchange listings for improved visibility.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BAT is an Ethereum-based token integrated into the privacy-focused web browser, Brave. The token is used as a payment method for running advertising campaigns through Brave Ads.
Read more on BAT →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →